Patent · US Active

Antibodies

US8822664B2 · kind B2 · utility

9Cited by

2References

15Claims

0Family size

Assignee

Affitech Research AS · NO

Inventors

Lavinia Diana Cicortas Gunnarsson · Oslo, NO
Didrik Paus · Oslo, NO

Key dates

Filing date	Mar 27, 2013
Grant date	Sep 2, 2014
Priority date	—
Expiry date	Apr 27, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides antibodies which bind to an epitope in the extracellular domain of human CC chemokine receptor 4 (CCR4) and which are capable of inhibiting the binding of macrophage-derived chemokine (MDC) and/or thymus and activation regulated chemokine (TARC) to CCR4. Also provided are inter alia immunoconjugates and compositions comprising such antibodies and methods and uses involving such antibodies, particularly in the medical and diagnostic fields.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.